Lobaplatin
- Generic Name
- Lobaplatin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H18N2O3Pt
- CAS Number
- 135558-11-1
- Unique Ingredient Identifier
- OX5XK1JD8C
Overview
Lobaplatin has been used in trials studying the treatment of Breast Cancer, Hepatocellular Carcinoma, and Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma.
Background
Lobaplatin has been used in trials studying the treatment of Breast Cancer, Hepatocellular Carcinoma, and Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma.
Indication
主要用于治疗乳腺癌、小细胞肺癌及慢性粒细胞白血病。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath